Publications by authors named "Fabrice Jardin"

100Publications

Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma.

Cancers (Basel) 2020 Sep 30;12(10). Epub 2020 Sep 30.

INSERM U1245, Unicaen, Normandie University, F-14000 Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12102829DOI Listing
September 2020

Castleman's disease in two patients with spondyloarthritis treated by Tumor Necrosis Factor-alpha antagonists.

Joint Bone Spine 2020 Jul 1. Epub 2020 Jul 1.

Department of Rheumatology, CIC/CRB 1404, Rouen University Hospital, Normandie Univ, UNIROUEN, 76000 Rouen, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2020.06.012DOI Listing
July 2020

EBV+ diffuse large B-cell lymphoma associated with chronic inflammation expands the spectrum of breast implant-related lymphomas.

Blood 2020 May;135(22):2004-2009

Department of Biopathology and Tumor Immunology, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique UMR 7258, Aix-Marseille University, UM105, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019003408DOI Listing
May 2020

[Low-grade dural extranodal marginal zone lymphoma].

Ann Pathol 2020 Jun 13;40(3):243-247. Epub 2020 Jan 13.

Inserm U1245, service d'anatomie pathologique, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2019.12.006DOI Listing
June 2020

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.

Neurology 2020 03 6;94(10):e1027-e1039. Epub 2020 Jan 6.

From Service de Neurologie 2-Mazarin, Sorbonne Université, IHU, ICM (C. Houillier, A.A., D.D., H.D., D.G., B.A., K.H.-X.), Service d'Hématologie (S. Choquet), Service de Neuro-Radiologie (N.M.-D.), Service d'Ophtalmologie (V.T.), Service de Médecine Nucléaire (A.K.), Service de Neuro-Pathologie (K.M.), Service d'Anatomie et Cytologies Pathologiques (F.C.), Service de Radiothérapie (L.F.), Service d'Hémato-Biologie (M.L.G.-T., M.C.), and Service de Neurochirurgie (B.M., M.P.), APHP, Groupe Hospitalier Pitié-Salpêtrière, Paris; Service d'Hématologie (C. Soussain), Institut Curie, Site Saint-Cloud; Service d'Hématologie (H.G.), CHU Lyon Sud; Service d'Hématologie (P.S., A.S.), Institut Bergonié, Bordeaux; Service de Neuro-Oncologie (O. Chinot), Aix-Marseille Université, CNRS, INP, AP-HM, CHU de la Timone, Marseille; Service de Neurologie (L.T., M.B.), CHU de Nancy; Service d'Hématologie (R.H.), Inserm U1236 Université de Rennes 1 (T.L.), CHU de Rennes; Service de Neurologie (G.A.), Hôpitaux Civils, Colmar; Service d'Hématologie (G.D.), CHU de Caen; Service d'Oncologie Médical (P.A.), Institut de Cancérologie de l'Ouest, Saint Herblain; Service d'Hématologie (C.M.-C.), CHU de Clermont-Ferrand; Service de Neurologie (A.A.), CHU de Toulouse; Service d'Oncologie Hématologique et de Thérapie Cellulaire (V.D.), CHU de Poitiers, INSERM, CIC 1402, Centre d'Investigation Clinique, Université de Poitiers; Service d'Oncologie Médicale (M.F.), Institut du Cancer de Montpellier Val d'Aurelle; Service d'Hématologie (F.J.), Centre Henri Becquerel, Rouen; Service d'Hématologie (A.C.), CHU de Besançon; Service d'Hématologie (M.P.M.-M.), CHU d'Angers; Service d'Hématologie (F.M., E.B.), CHRU de Lille; Service d'Hématologie (O. Casasnovas), CHU de Dijon; Service d'Onco-Hématologie (R.G.), CHU de Grenoble; Service d'Hématologie (L.M.F.), CHU de Strasbourg; Service d'Hématologie (J.A.), CHU de Limoges; Service d'Hématologie (J.-P.M.), CHU d'Amiens; Service d'Hématologie (A.T.), CHU de Brest; Service de Neurologie (C.C.) and Service d'Hématologie (A.W.), CHU de Nîmes; Clinique Courlancy (P.C.), Reims; Service d'Hématologie (J.T.), Hôpital Cochin, APHP, Paris; Service d'Hématologie Clinique (K.L.), Centre Hospitalier, Le Mans; Service d'Hématologie (C. Serrier), Centre Hospitalier de Perpignan; Service d'Hématologie (C. Haioun), Hôpital Henri Mondor, Créteil, APHP; Service d'Hématologie Clinique (S. Chebrek), Centre Hospitalier d'Avignon; Service d'Hématologie (J.O.B.), CHU de Clermont-Ferrand; Service d'Hématologie (L.O.), Institut Universitaire du Cancer de Toulouse; Service de Neuro-Oncologie (E.T.), Aix-Marseille Univ, CNRS, INP, AP-HM, CHU de la Timone; Service d'Ophtalmologie (N.C.), Institut Curie, Université Paris V Descartes et PSL (Paris Science et Lettre), Paris; and Service d'Hématologie et Thérapie Cellulaire (E.G.), Centre d'Investigations Cliniques INSERM U1517, Centre Hospitalier Universitaire, Université de Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238921PMC
March 2020

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

Authors:
Francine Garnache-Ottou Chrystelle Vidal Sabeha Biichlé Florian Renosi Eve Poret Maïder Pagadoy Maxime Desmarets Anne Roggy Estelle Seilles Lou Soret Françoise Schillinger Sandrine Puyraimond Tony Petrella Claude Preudhomme Christophe Roumier Elisabeth A MacIntyre Véronique Harrivel Yohan Desbrosses Bérengère Gruson Franck Geneviève Sylvain Thepot Yuriy Drebit Thibaut Leguay François-Xavier Gros Nicolas Lechevalier Pascale Saussoy Véronique Salaun Edouard Cornet Zehaira Benseddik Richard Veyrat-Masson Orianne Wagner-Ballon Célia Salanoubat Marc Maynadié Julien Guy Denis Caillot Marie-Christine Jacob Jean-Yves Cahn Rémy Gressin Johann Rose Bruno Quesnel Estelle Guerin Franck Trimoreau Jean Feuillard Marie-Pierre Gourin Adriana Plesa Lucile Baseggio Isabelle Arnoux Norbert Vey Didier Blaise Romaric Lacroix Christine Arnoulet Blandine Benet Véronique Dorvaux Caroline Bret Bernard Drenou Agathe Debliquis Véronique Latger-Cannard Caroline Bonmati Marie-Christine Bene Pierre Peterlin Michel Ticchioni Pierre-Simon Rohrlich Anne Arnaud Stefan Wickenhauser Valérie Bardet Sabine Brechignac Benjamin Papoular Victoria Raggueneau Jacques Vargaftig Rémi Letestu Daniel Lusina Thorsten Braun Vincent Foissaud Jérôme Tamburini Hind Bennani Nicolas Freynet Catherine Cordonnier Magali Le Garff-Tavernier Nathalie Jacques Karim Maloum Damien Roos-Weil Didier Bouscary Vahid Asnafi Ludovic Lhermitte Felipe Suarez Etienne Lengline Frédéric Féger Giorgia Battipaglia Mohamad Mohty Sabrina Bouyer Ouda Ghoual Elodie Dindinaud Caroline Basle Mathieu Puyade Carinne Lafon Thierry Fest Mikael Roussel Xavier Cahu Elsa Bera Sylvie Daliphard Fabrice Jardin Lydia Campos Françoise Solly Denis Guyotat Anne-Cécile Galoisy Alice Eischen Caroline Mayeur-Rousse Blandine Guffroy Christian Recher Marie Loosveld Alice Garnier Vincent Barlogis Maria Alessandra Rosenthal Sophie Brun Nathalie Contentin Sébastien Maury Mary Callanan Christine Lefebvre Natacha Maillard Patricia Okamba Christophe Ferrand Olivier Adotevi Philippe Saas Fanny Angelot-Delettre Delphine Binda Eric Deconinck

Blood Adv 2019 12;3(24):4238-4251

University of Bourgogne Franche-Comté, INSERM, Établissement Français du Sang Bourgogne/Franche-Comté, Unite Mixte de Recherche (UMR) 1098, RIGHT (Interactions Greffon-Hôte-Tumeur/Ingénierie Cellulaire et Génique), Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000647DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929390PMC
December 2019

Cell-free DNA and the monitoring of lymphoma treatment.

Pharmacogenomics 2019 12 8;20(18):1271-1282. Epub 2019 Nov 8.

Department of Hematology, Centre Henri Becquerel, 1 Rue D'Amiens, 76038 Rouen Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2019-0099DOI Listing
December 2019

Ocular adnexal marginal zone B-cell lymphoma: the low-dose dilemma.

Br J Ophthalmol 2020 02 11;104(2):151-152. Epub 2019 Oct 11.

Department of Hematology, Centre Henri Becquerel, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bjophthalmol-2019-314861DOI Listing
February 2020

Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type.

J Invest Dermatol 2019 11 29;139(11):2334-2342.e8. Epub 2019 May 29.

INSERM U1053, Equipe Oncogenèse des lymphomes cutanés, Université de Bordeaux; Service de Biologie des tumeurs, CHU de Bordeaux, Pessac, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2019.05.008DOI Listing
November 2019

Improving R-CHOP in diffuse large B-cell lymphoma is still a challenge.

Authors:
Fabrice Jardin

Lancet Oncol 2019 05 1;20(5):605-606. Epub 2019 Apr 1.

Department of Clinical Hematology, Centre Henri Becquerel, INSERM U1245, Rouen University, Rouen 76038, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30021-XDOI Listing
May 2019

Benefit of cetuximab addition to a platinum-fluorouracil-based chemotherapy according to KRAS-LCS6 variant in an unselected population of recurrent and/or metastatic head and neck cancers.

Eur Arch Otorhinolaryngol 2019 Feb 6;276(2):541-550. Epub 2018 Dec 6.

IRON Group, Normandy Centre for Genomic and Personalized Medicine, Rouen University Hospital, UNIROUEN, Inserm U1245, rue de Germont, Normandie Université, 76000, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-018-5235-6DOI Listing
February 2019

(teleomorph ) candidaemia in a patient with aplastic anaemia: a case report.

JMM Case Rep 2018 Aug 10;5(8):e005160. Epub 2018 Jul 10.

INSERM U1245, Department of Hematology, Centre Henri Becquerel, Université of Rouen Normandie, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1099/jmmcr.0.005160DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152400PMC
August 2018

Prognostic impact of diagnosis to treatment interval (DTI) in diffuse large B-cell lymphoma patients: a real-life monocentric study.

Leuk Lymphoma 2019 03 20;60(3):839-841. Epub 2018 Sep 20.

a Department of Hematology , Centre Henri Becquerel , Rouen , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1508671DOI Listing
March 2019

Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease.

Am J Surg Pathol 2019 01;43(1):110-120

Institute of Pathology and Neuropathology and Comprehensive Cancer Center Tübingen, University Hospital Tübingen, Eberhard-Karls-University, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001154DOI Listing
January 2019

Correction to: Tumor fragmentation estimated by volume surface ratio of tumors measured on F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Eur J Nucl Med Mol Imaging 2018 09;45(10):1838-1839

Department of Nuclear Medicine, Henri Becquerel Cancer Centre, Rue d'Amiens - CS 11516, 76038, Rouen Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-018-4053-9DOI Listing
September 2018

Novel molecular classifications of DLBCL.

Nat Rev Clin Oncol 2018 08;15(8):474-476

Centre Henri Becquerel, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0041-zDOI Listing
August 2018

Tumor fragmentation estimated by volume surface ratio of tumors measured on 18F-FDG PET/CT is an independent prognostic factor of diffuse large B-cell lymphoma.

Eur J Nucl Med Mol Imaging 2018 09 28;45(10):1672-1679. Epub 2018 Apr 28.

Department of Nuclear Medicine, Henri Becquerel Cancer Centre, Rue d'Amiens - CS 11516, 76038, Rouen Cedex 1, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00259-018-4041-0
Publisher Site
http://dx.doi.org/10.1007/s00259-018-4041-0DOI Listing
September 2018

STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.

Cell Signal 2018 06 1;46:76-82. Epub 2018 Mar 1.

Normandie Univ, INSERM UMR1245, UNICAEN, Caen, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2018.02.016DOI Listing
June 2018

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

N Engl J Med 2017 09;377(13):1250-1260

From Service d'Hématologie Clinique (S.L.G., T.G.), Service d'Anatomopathologie (A.M.), and Service d'Hématologie Biologique (M.C.B.), Hôtel-Dieu Centre Hospitalier Universitaire (CHU) de Nantes, and Centre de Recherche en Cancérologie et Immunologie (S.L.G., M.C.B.) and Faculté de Médecine (S.L.G.), Université de Nantes, Nantes, Hemato-Oncologie, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Université Diderot Sorbonne Paris-Cité (C.T.), Université Descartes (C.T.), Département d'Hématologie, Faculté de Médecine, Université Paris-Sud (V.R.), Département d'Anatomopathologie (D.C.) and Département d'Hématologie (O.H.), Necker Hospital, APHP, Sorbonne Paris-Cité, and INSERM Unité 1163 et Centre National de la Recherche Scientifique (CNRS) Équipe de Recherche Labellisée 8654, Imagine Institute (O.H.), Paris, Département d'Hématologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse (L.O.), Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux, Bordeaux (K.B.), Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours (C.D.), Service d'Hématologie, CHU d'Amiens, Amiens (G.D.), INSERM, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif (V.R.), Département d'Hématologie, CHU de Nancy, Nancy (P.F.), INSERM Unité 954, Vandoeuvre (P.F.), Service d'Hématologie Clinique, CHU de Dijon, and INSERM Unité Mixte de Recherche 1231, Dijon (O.C.), Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon (H.Z.), Lymphoid Malignancies Unit, Hôpital Henri Mondor, APHP, Créteil (C.H.), Service d'Hématologie du Centre Hospitalier de Vendée, La Roche-sur-Yon (H.M.), Service Hématologie Clinique (R.H.) and Département d'Hématologie (T.L.), CHU de Rennes, INSERM Unité 917 (R.H.), and INSERM Unité 1236 (T.L.), Rennes, Département d'Hematology, Centre Henri-Becquerel et Université de Normandie Unité 1245, Rouen (F.J., H.T.), Service d'Hématologie Clinique Adulte et de Thérapie Cellulaire, CHU de Clermont-Ferrand et Université Clermont Auvergne, Clermont-Ferrand (O.T.), Service d'Hématologie, Clinique Victor Hugo, Le Mans (K.L.D.), Department of Hematology, Université de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, and CHU de Lille, Lille (F.M.), Département d'Hématologie Clinique, CHU de Montpellier, CNRS UMR 5235, Montpellier (G.C.), Service d'Oncologie et d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg (L.-M.F.), INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble Alpes (M.C., R.G.), Institute for Advanced Biosciences (M.C.), and Laboratoire de Génétique Onco-hématologie (M.C.) and Faculté de Médecine (R.G.), CHU de Grenoble Alpes, Grenoble, Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite (G.S.), and Université Claude Bernard Lyon 1 and Cancer Research Center of Lyon, INSERM 1052 CNRS 5286 Lyon, Lyon (G.S.) - all in France; and Département d'Hématologie, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Brussels (E.V.D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701769DOI Listing
September 2017

Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells.

Leuk Res 2017 09 16;60:53-57. Epub 2017 Jun 16.

Henri Becquerel Center, INSERM U918, Institut de Recherche et d'Innovation Biomédicale (iRiB) Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.06.006DOI Listing
September 2017

Osteonecrosis of the Jaw in a Patient Presenting With Post-Transplantation Lymphoproliferative Disorder Treated With Rituximab: A Case Report.

J Oral Maxillofac Surg 2017 Dec 24;75(12):2599-2605. Epub 2017 May 24.

Head of Department, Department of Oral Surgery and Odontology, Rouen University Hospital, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2017.05.016DOI Listing
December 2017

The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.

Expert Rev Mol Diagn 2017 06 27;17(6):557-566. Epub 2017 Apr 27.

c University of Rouen - Department of Hematology , Centre Henri Becquerel , Rouen , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2017.1319765DOI Listing
June 2017

XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.

J Hematol Oncol 2017 02 14;10(1):47. Epub 2017 Feb 14.

Normandie Univ, INSERM U1245, UNICAEN, UNIROUEN, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-017-0412-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307790PMC
February 2017

Molecular Profile and FDG-PET Metabolic Volume at Staging in DLBCL-Response.

Clin Cancer Res 2016 07;22(13):3414-5

Nuclear Medicine Department, Henri Becquerel Cancer Center and Rouen University Hospital, Rouen, France. QuantIF-LITIS (EA 4108-FR CNRS 3638), Faculty of Medicine, University of Rouen, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-0783DOI Listing
July 2016

Selecting radiomic features from FDG-PET images for cancer treatment outcome prediction.

Med Image Anal 2016 08 19;32:257-68. Epub 2016 May 19.

Université de Rouen, QuantIF, EA 4108 LITIS, France; Centre Henri-Becquerel, Department of Nuclear Medicine, France.

View Article

Download full-text PDF

Source
https://www.hds.utc.fr/~tdenoeux/dokuwiki/_media/en/publi/mi
Web Search
http://dx.doi.org/10.1016/j.media.2016.05.007DOI Listing
August 2016

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Neuro Oncol 2016 09 6;18(9):1297-303. Epub 2016 Mar 6.

Department of Neurology, Centre Hospitalier Universitaire de Rennes, Rennes, France (S.L.-L.); Department of Neurology Mazarin, APHP, Sorbonne Universités UPMC Univ Paris VI, IHU, ICM, INCa-LOC Network, Groupe Hospitalier Pitié-Salpétrière, Paris, France (C.H., K.H.-X.); Department of Hematology, Hôpital René Huguenin-Institut Curie, Saint-Cloud, Collège de France, Paris, France (C.S.); Department of Hematology, Centre Léon Bérard, Lyon, France (H.G.); Department of Neurooncology, Centre Hospitalier Universitaire La Timone, Assistance Publique-Hôpitaux de Marseille, INSERM U911, CRO2, Université de la Méditerranée, Marseille, France (O.C.); Department of Neurology, Centre Hospitalier Universitaire de Nancy, Nancy, France (L.T.); Department of Hematology, Institut Bergonié, Bordeaux, France (P.S.); Department of Hematology, Centre Hospitalier Universitaire de Rennes, INSERM U917, Rennes, France (T.L., R.H.); Department of Hematology, Centre Hospitalier Universitaire de Lille, Lille, France (F.M.); Department of Neurology, Centre Hospitalier Universitaire Toulouse-Purpan, Toulouse, France (A.B.-A.); Department of Neurology, Hôpitaux Civils de Colmar, Colmar, France (G.A.); Department of Hematology, Centre Hospitalier Universitaire d'Angers, Angers, France (M.-P.M.-M.); Department of Hematology, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France (C.M.-C.); Department of Hematology and Oncology, Centre Hospitalier Universitaire de Nîmes, Nîmes, France (P.B.); Department of Hematology, Centre Hospitalier Universitaire de Caen, Caen, France (G.D., O.R.); Department of Hematology, Centre Henri Becquerel, Université de Rouen, INSERM U918, Rouen, France (F.J.); Department of Neurology, Centre Hospitalier Universitaire de Poitiers, Poitiers, France (D.L.); Department of Hematology and Cell Therapy, Centre Hospitalier Universitaire de Tours, CIC, INSERM U1415, Tours, France (E.G.); Department of Hematology, Centre Hospitalier Unive

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/now033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998995PMC
September 2016

Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.

Clin Cancer Res 2016 08 2;22(15):3801-9. Epub 2016 Mar 2.

Nuclear Medicine Department, Henri Becquerel Cancer Center and Rouen University Hospital, Rouen, France. QuantIF-LITIS (EA 4108-FR CNRS 3638), Faculty of Medicine, University of Rouen, Rouen, France.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/early/2016/03/
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2825DOI Listing
August 2016

The role of next-generation sequencing in understanding the genomic basis of diffuse large B cell lymphoma and advancing targeted therapies.

Expert Rev Hematol 2016 Mar 14;9(3):255-69. Epub 2016 Jan 14.

a Inserm U918, Centre Henri Becquerel , Université de Rouen, IRIB , Rouen , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2016.1130616DOI Listing
March 2016

Spontaneous remission in three cases of AML M5 with NPM1 mutation.

Clin Case Rep 2015 Nov 21;3(11):955-9. Epub 2015 Oct 21.

Department of Haematology, Centre Henri Becquerel Rue d'Amiens, 76038, Rouen, France ; INSERM U918, Centre Henri Becquerel Rue d'Amiens, 76038, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641483PMC
November 2015

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

J Clin Oncol 2015 Nov 12;33(33):3930-7. Epub 2015 Oct 12.

Hervé Ghesquieres, Universite Claude Bernard Lyon 1, Centre Leon Berard; Amelie S. Veron and David G. Cox, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U1052, Cancer Research Center of Lyon, Centre Leon Berard, Lyon; Hervé Ghesquieres and Gilles A. Salles, Faculté de Médecine Lyon-Sud; Gilles A. Salles, Universite Claude Bernard Lyon 1, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite; Fabrice Jardin, Sylvain Mareschal, and Herve Tilly, INSERM U918, Centre Henri Becquerel, Rouen; Thierry Fest, INSERM U917, Université de Rennes 1, Hopital Pontchaillou; Thierry Lamy, Université de Rennes 1, Hopital Pontchaillou, Rennes; Marie C. Bene, Centre Hospitalier Universitaire Nantes, Nantes; Corinne Haioun, Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris (AP-HP) and University Paris Est, Créteil; Thierry Jo Molina, Universite Paris Descartes, AP-HP, Hôpital Necker, Paris; Noel Milpied, University Hospital and University of Bordeaux, Bordeaux, France; Hervé Ghesquieres, Susan L. Slager, Matthew J. Maurer, Thomas M. Habermann, Anne J. Novak, Stephen M. Ansell, Thomas E. Witzig, Andrew L. Feldman, Ahmet Dogan, Julie M. Cunningham, Curtis L. Olswold, and James R. Cerhan, Mayo Clinic, Rochester, MN; Yan W. Asmann, Mayo Clinic, Jacksonville, FL; and George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.2573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879713PMC
November 2015

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma.

Blood 2015 Jul 28;126(5):604-11. Epub 2015 May 28.

Department of Internal Medicine III, University Hospital Munich, Munich, Germany; Department of Medical Informatics, Biometry, and Epidemiology, University of Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-02-628792DOI Listing
July 2015

Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.

Haematologica 2015 May 30;100(5):e204-6. Epub 2015 Jan 30.

Anticancer Antibody Team, INSERM U1052, CNRS UMR 5286, Cancer Research Center of Lyon, France Hospices Civils de Lyon, France ProfileXpert, Lyon, France Laboratory of Hematology, Hospices Civils de Lyon, Pierre-Bénite, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.120113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420233PMC
May 2015

CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.

Pathology 2015 Jan;47(1):45-50

1Department of Medical Oncology, Centre Henri Becquerel, IRON, Rouen 2INSERM U918, Centre Henri Becquerel, IRIB, Rouen 3Department of Pathology, Centre Henri Becquerel, Rouen 4Department of Head and Neck Surgery, Hospital Charles Nicolle, Rouen 5Department of Head and Neck Surgery, Centre Henri Becquerel, Rouen 6Department of Pathology, Hospital Charles Nicolle, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000191DOI Listing
January 2015

Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lymphoma study association phase III trial LNH 03-2B.

J Clin Oncol 2014 Dec 10;32(35):3996-4003. Epub 2014 Nov 10.

Thierry Jo Molina, Danielle Canioni, and Jean-Philippe Jais, Assistance Publique-Hôpitaux de Paris (AP-HP), Necker Enfants-Malades, Université Paris Descartes, EA 7324, Sorbonne Paris Cité; Josette Brière and Catherine Thieblemont, AP-HP, Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité; Catherine Thieblemont, L'Institut National de la Santé et de la Recherche Médicale (INSERM) U728; Bettina Fabiani, AP-HP, Saint-Antoine, Paris; Christiane Copie-Bergman, Corinne Haioun, Karen Leroy, and Philippe Gaulard, AP-HP, Groupe Hospitalier Henri-Mondor/Albert-Chenevier, Université Paris-Est Créteil; Christiane Copie-Bergman, Karen Leroy, and Philippe Gaulard, INSERM Unité U955 Équipe 9, Créteil; Christian Recher, Centre Hospitalier Universitaire (CHU) Purpan, Université Toulouse III Paul Sabatier, Toulouse; Françoise Berger, Gilles Salles, and Bertrand Coiffier, Hospices Civils de Lyon, Université Claude Bernard, Pierre-Bénite; Christophe Fermé, Institut Gustave Roussy, Villejuif; Marie-Christine Copin and Franck Morschauser, CHU Lille, Lille; Olivier Casasnovas and Tony Petrella, CHU Dijon, Dijon; Nicolas Mounier, CHU Nice, Nice; and Fabrice Jardin and Hervé Tilly, Centre Henri Becquerel, Université de Rouen, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.9493DOI Listing
December 2014

CD70: A Potential Target in Breast Cancer?

J Cancer 2014 22;5(9):761-4. Epub 2014 Oct 22.

1. Department of Medical Oncology, Centre Henri Becquerel, Rouen, France; ; 3. INSERM U918, Centre Henri Becquerel, IRIB, Rouen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.10360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216800PMC
November 2014

Body mass index and other anthropometric parameters in patients with diffuse large B-cell lymphoma: physiopathological significance and predictive value in the immunochemotherapy era.

Leuk Lymphoma 2015 Jul 21;56(7):1959-68. Epub 2015 Jan 21.

Department of Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Université Claude Bernard , Pierre Bénite , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.979412DOI Listing
July 2015